180 related articles for article (PubMed ID: 19085383)
21. Peroxisome proliferator-activated receptor-gamma ligands inhibit choroidal neovascularization.
Murata T; He S; Hangai M; Ishibashi T; Xi XP; Kim S; Hsueh WA; Ryan SJ; Law RE; Hinton DR
Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2309-17. PubMed ID: 10892878
[TBL] [Abstract][Full Text] [Related]
22. Dose-dependent effect of pitavastatin on VEGF and angiogenesis in a mouse model of choroidal neovascularization.
Zambarakji HJ; Nakazawa T; Connolly E; Lane AM; Mallemadugula S; Kaplan M; Michaud N; Hafezi-Moghadam A; Gragoudas ES; Miller JW
Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2623-31. PubMed ID: 16723479
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of choroidal neovascularisation in mice by systemic administration of the multikinase inhibitor, sorafenib.
Chung EJ; Yoo S; Lim HJ; Byeon SH; Lee JH; Koh HJ
Br J Ophthalmol; 2009 Jul; 93(7):958-63. PubMed ID: 19028740
[TBL] [Abstract][Full Text] [Related]
24. Slit2 Promotes Angiogenic Activity Via the Robo1-VEGFR2-ERK1/2 Pathway in Both In Vivo and In Vitro Studies.
Li S; Huang L; Sun Y; Bai Y; Yang F; Yu W; Li F; Zhang Q; Wang B; Geng JG; Li X
Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5210-7. PubMed ID: 26244297
[TBL] [Abstract][Full Text] [Related]
25. Soluble EphB4 regulates choroidal endothelial cell function and inhibits laser-induced choroidal neovascularization.
He S; Ding Y; Zhou J; Krasnoperov V; Zozulya S; Kumar SR; Ryan SJ; Gill PS; Hinton DR
Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4772-9. PubMed ID: 16303978
[TBL] [Abstract][Full Text] [Related]
26. Effect of chromogranin A-derived vasostatin-1 on laser-induced choroidal neovascularization in the mouse.
Maestroni S; Maestroni A; Ceglia S; Tremolada G; Mancino M; Sacchi A; Lattanzio R; Zucchiatti I; Corti A; Bandello F; Zerbini G
Acta Ophthalmol; 2015 May; 93(3):e218-22. PubMed ID: 25271003
[TBL] [Abstract][Full Text] [Related]
27. Brivanib, a multitargeted small-molecule tyrosine kinase inhibitor, suppresses laser-induced CNV in a mouse model of neovascular AMD.
Li L; Zhu M; Wu W; Qin B; Gu J; Tu Y; Chen J; Liu D; Shi Y; Liu X; Sang A; Ding D
J Cell Physiol; 2020 Feb; 235(2):1259-1273. PubMed ID: 31270802
[TBL] [Abstract][Full Text] [Related]
28. Suppression of choroidal neovascularization by vaccination with epitope peptide derived from human VEGF receptor 2 in an animal model.
Takahashi H; Ishizaki H; Tahara H; Tamaki Y; Yanagi Y
Invest Ophthalmol Vis Sci; 2008 May; 49(5):2143-7. PubMed ID: 18436847
[TBL] [Abstract][Full Text] [Related]
29. Inhibitory effect of YC-1, 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole, on experimental choroidal neovascularization in rat.
Song SJ; Chung H; Yu HG
Ophthalmic Res; 2008; 40(1):35-40. PubMed ID: 18032914
[TBL] [Abstract][Full Text] [Related]
30. Pseudolarix acid B inhibits angiogenesis by antagonizing the vascular endothelial growth factor-mediated anti-apoptotic effect.
Tan WF; Zhang XW; Li MH; Yue JM; Chen Y; Lin LP; Ding J
Eur J Pharmacol; 2004 Sep; 499(3):219-28. PubMed ID: 15381043
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological characterization of CP-547,632, a novel vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for cancer therapy.
Beebe JS; Jani JP; Knauth E; Goodwin P; Higdon C; Rossi AM; Emerson E; Finkelstein M; Floyd E; Harriman S; Atherton J; Hillerman S; Soderstrom C; Kou K; Gant T; Noe MC; Foster B; Rastinejad F; Marx MA; Schaeffer T; Whalen PM; Roberts WG
Cancer Res; 2003 Nov; 63(21):7301-9. PubMed ID: 14612527
[TBL] [Abstract][Full Text] [Related]
32. Systemic rapamycin inhibits retinal and choroidal neovascularization in mice.
Dejneka NS; Kuroki AM; Fosnot J; Tang W; Tolentino MJ; Bennett J
Mol Vis; 2004 Dec; 10():964-72. PubMed ID: 15623986
[TBL] [Abstract][Full Text] [Related]
33. Antiangiogenic effects of axitinib, an inhibitor of vascular endothelial growth factor receptor tyrosine kinase, on laser-induced choroidal neovascularization in mice.
Kang S; Roh CR; Cho WK; Park KC; Yang KJ; Choi HS; Kim SH; Roh YJ
Curr Eye Res; 2013 Jan; 38(1):119-27. PubMed ID: 23013553
[TBL] [Abstract][Full Text] [Related]
34. Tissue inhibitor of metalloproteinases-3 peptides inhibit angiogenesis and choroidal neovascularization in mice.
Qi JH; Ebrahem Q; Ali M; Cutler A; Bell B; Prayson N; Sears J; Knauper V; Murphy G; Anand-Apte B
PLoS One; 2013; 8(3):e55667. PubMed ID: 23469166
[TBL] [Abstract][Full Text] [Related]
35. Methallothionein-3 contributes to vascular endothelial growth factor induction in a mouse model of choroidal neovascularization.
Choi JA; Hwang JU; Yoon YH; Koh JY
Metallomics; 2013 Oct; 5(10):1387-96. PubMed ID: 23962989
[TBL] [Abstract][Full Text] [Related]
36. A selective and oral small molecule inhibitor of vascular epithelial growth factor receptor (VEGFR)-2 and VEGFR-1 inhibits neovascularization and vascular permeability.
Patel N; Sun L; Moshinsky D; Chen H; Leahy KM; Le P; Moss KG; Wang X; Rice A; Tam D; Laird AD; Yu X; Zhang Q; Tang C; McMahon G; Howlett A
J Pharmacol Exp Ther; 2003 Sep; 306(3):838-45. PubMed ID: 12766257
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of VEGF secretion and experimental choroidal neovascularization by picropodophyllin (PPP), an inhibitor of the insulin-like growth factor-1 receptor.
Economou MA; Wu J; Vasilcanu D; Rosengren L; All-Ericsson C; van der Ploeg I; Menu E; Girnita L; Axelson M; Larsson O; Seregard S; Kvanta A
Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2620-6. PubMed ID: 18515591
[TBL] [Abstract][Full Text] [Related]
38. The role of estrogen and estrogen receptorbeta in choroidal neovascularization.
Tanemura M; Miyamoto N; Mandai M; Kamizuru H; Ooto S; Yasukawa T; Takahashi M; Honda Y
Mol Vis; 2004 Dec; 10():923-32. PubMed ID: 15616479
[TBL] [Abstract][Full Text] [Related]
39. Technetium-99 conjugated with methylene diphosphonate (99Tc-MDP) inhibits experimental choroidal neovascularization in vivo and VEGF-induced cell migration and tube formation in vitro.
Lai K; Xu L; Jin C; Wu K; Tian Z; Huang C; Zhong X; Ye H
Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5702-12. PubMed ID: 21666238
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of choroidal neovascularization by homoisoflavanone, a new angiogenesis inhibitor.
Kim JH; Kim JH; Yu YS; Jun HO; Kwon HJ; Park KH; Kim KW
Mol Vis; 2008 Mar; 14():556-61. PubMed ID: 18385791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
